Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis

Breast Cancer Research and Treatment

Volumn 137, Issue 2, 2013, Pages 337-347

  Antoni, Sebastien ^a   Sasco, Annie J ^b,c   Dos Santos Silva, Isabel ^d   McCormack, Valerie ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Breast cancer; Breast density; Receptor subtypes

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADULT; AGE; AGED; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TRIPLE NEGATIVE BREAST CANCER; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; CONGENITAL MALFORMATION; MAMMARY GLAND; METABOLISM; PATHOLOGY; RADIOGRAPHY;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN;

MLCS; MLOWN;

EID: 84874936441     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2362-4     Document Type: Review

References (39)

1. Boyd NF, Guo H, Martin LJ et al (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236
2. McCormack VA, dos Santos SilvaI (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159-1169
3. Cuzick J, Warwick J, Pinney E et al (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103:744-752
4. Greendale GA, Reboussin BA, Sie A et al (1999) Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 130:262-269
5. Phipps AI, Chlebowski RT, Prentice R et al (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:470-477
6. Tworoger SS, Eliassen AH, Sluss P et al (2007) A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 25:1482-1488
7. Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876-882
8. Greendale GA, Huang MH, Ursin G et al (2007) Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat 105:337-346
9. McCormack VA, Dowsett M, Folkerd E et al (2009) Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res 11:R38
10. Ghosh S, Kang T, Wang H et al (2011) Mechanical phenotype is important for stromal aromatase expression. Steroids 76:797-801
11. Boyd NF, Rommens JM, Vogt K et al (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808
12. Ritte RE, Lukanova A, Dossus L et al (2011) Postmenopausal serum sex steroids and risk of hormone receptor positive and negative breast cancer: a nested case-control study. Cancer Prev Res (Phila) 4:1626-1635
13. Evans DG, Warwick J, Astley SM et al (2012) Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res (Phila) 5:943-951
14. Conroy SM, Pagano I, Kolonel LN et al (2011) Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol 35:448-452
15. Ziv E, Tice J, Smith-Bindman R et al (2004) Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 13:2090-2095
16. Phipps AI, Buist DS, Malone KE et al (2012) Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 22:340-348
17. Eriksson L, Hall P, Czene K et al (2012) Mammographic density and molecular subtypes of breast cancer. Br J Cancer 107:18-23
18. Yaghjyan L, Colditz GA, Collins LC et al (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 103:1179-1189
19. Ding J, Warren R, Girling A et al (2010) Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 16:279-289
20. Olsen AH, Bihrmann K, Jensen MB et al (2009) Breast density and outcome of mammography screening: a cohort study. Br J Cancer 100:1205-1208
21. Arora N, King TA, Jacks LM et al (2010) Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 17(Suppl 3):211-218
22. Hinton CP, Williams MR, Roebuck EJ et al (1984) The relationship of background mammographic pattern to hormone dependency in breast cancer. Br J Surg 71:357-359
23. Ma H, Luo J, Press MF et al (2009) Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 18:479-485
24. Moller Nielsen NS, Poulsen HS (1985) Relation between mammographic findings and hormonal receptor content in breast cancer. AJR Am J Roentgenol 145:501-504
25. Chen JH, Hsu FT, Shih HN et al (2009) Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol 20:1447-1449
26. Aiello EJ, Buist DS, White E et al (2005) Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 14:662-668
27. Fasching PA, Heusinger K, Loehberg CR et al (2006) Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol 60:398-404
28. Yang WT, Dryden M, Broglio K et al (2008) Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 111:405-410
29. Gierach GL, Ichikawa L, Kerlikowske K et al (2012) Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 104:1218-1227
30. Collett K, Stefansson IM, Eide J et al (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 14:1108-1112
31. Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081-1087
32. Pike MC, Krailo MD, Henderson BE et al (1983) 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303:767-770
33. Defilippis RA, Chang H, Dumont N et al (2012) CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov 2:826-839
34. Ciatto S, Cecchini S, Iossa A et al (1989) Association of estrogen receptors with parenchymal pattern at mammography. Radiology 170:695-697
35. Nielsen NS, Andersen J, Poulsen HS et al (1992) Prediction of hormone responsiveness by mammographic parenchymal pattern in advanced primary breast cancer. Breast Cancer Res Treat 23:219-222
36. Roubidoux MA, Bailey JE, Wray LA et al (2004) Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology 230:42-48
37. Boyd NF, Fishell E, Tonkin K et al (1987) Age as a confounding factor in the association of mammographic dysplasia and estrogen receptor concentration in breast cancer. Breast Cancer Res Treat 10:51-54
38. Ghosh K, Brandt KR, Sellers TA et al (2008) Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:872-879
39. Heusinger K, Jud SM, Haberle L et al (2012) Association of mammographic density with hormone receptors in invasive breast cancers - results from a case-only study. Int J Cancer. doi: 10.1002/ijc.27515